A second strain of enterococcus (PA) producing beta-lactamase (Bla+ phenotype) was 
Gmr and Bla+ with transfer of resistance to streptomycin, tetracycline, and chloramphenicol. EcoRI digestion of plasmid DNA from Gmr Bla+ transconjugants showed no similarities between the two strains. A 5.1-kilobase EcoRI Bla+-encoding fragment derived from HH22 was cloned into an Escherichia coli cloning vector and shown to hybridize to a 10.2-kilobase EcoRI fragment derived from PA; both fragments hybridized to an 840-base-pair staphylococcal Bla+ gene probe. These data indicate that the penicillinases are similar but encoded on different or differently arranged plasmids. The fact that both are transferable emphasizes the potential for this new streptococcal resistance determinant to disseminate.
Beta-lactamase production is one of the most common mechanisms by which bacteria resist the effects of penicillins. With some species, such as Pseudomonas aeruginosa and Enterobacter sp., beta-lactamase production (Bla+ phenotype) is an inherent characteristic that is chromosomally mediated. In others, beta-lactamase is acquired. For example, before the introduction of penicillin, Staphylococcus aureus was almost uniformly susceptible to this antibiotic; after a short period of widespread use, beta-lactamaseproducing, penicillin-resistant (Pc') staphylococci emerged and have subsequently replaced their penicillin-susceptible counterparts (13) . Despite several decades of penicillin use, some common pathogenic bacteria, such as Hemophilus influenzae and Neisseria gonorrheae, acquired betalactamase only recently (13) , and there has been a single report of penicillinase production in Neisseria meningitidis (3) . Other major pathogenic organisms shown recently to produce beta-lactamase are members of the family Streptococcaceae (11) . We first reported a strain of Streptococcus faecalis with plasmid-mediated penicillinase production in 1983; this strain was also highly resistant to gentamicin and all currently available aminoglycosides. We netic properties of these two penicillinase-producing enterococcal strains.
MATERIALS AND METHODS
Bacterial strains and plasmids. S. faecalis HH22 is resistant to high levels (MIC greater than 2,000 ,ug/ml) of gentamicin and all other commercially available aminoglycosides (10, 11) ; it is also resistant to erythromycin and tetracycline and produces penicillinase. Strain PA was isolated from blood cultures from a patient in 1983 in Philadelphia and was identified by conventional methods as S. faecalis; it is resistant to erythromycin, chloramphenicol, and tetracycline and highly resistant to all aminoglycosides and produces penicillinase (Table 1) . A rifampin-resistant, fusidic acidresistant mutant of enterococcal strain JH2-7 (11) was used as the recipient for conjugation experiments. XH22 is a Gmr pcr (Bla+) transconjugant derived by transferring Gmr from HH22 to JH2-7. DH1 is an Escherichia coli recipient strain (4); pACYC184 is a 4.0-kilobase (kb) plasmid that mediates chloramphenicol (Cm') and tetracycline (Tc') resistance and is commonly used as an E. coli cloning vector (1) .
Beta-lactamase activity. For hydrolysis studies, PA was grown overnight in brain heart infusion (BHI) broth (BBL Microbiology Systems, Cockeysville, Md.), harvested, washed once in 0.1 M NaPO4 buffer, pH 7.0, harvested again, and suspended in 0.1 volume of the NaPO4 buffer. The supernatant was tested for beta-lactamase with 50 pLg of the chromogenic cephalosporin nitrocefin (Glaxo Pharmaceuticals, Ltd., Greenford, United Kingdom) per ml; after filter sterilization of the supernatant, a 100-fold concentration was achieved with a Diaflo Ultra-Filter PM10 (Amicon Corp., Danvers, Mass.), and the concentrate was retested with nitrocefin. The suspended pellet was also tested with nitrocefin. The effect of beta-lactamase production on susceptibility of PA to various agents was assessed by determining the MIC of these agents with high (107 CFU/ml) and low (103 CFU/ml) inocula. The macrotube method with BHI broth was used. The compounds used (Table 2) were obtained from their respective manufacturers or from Sigma Chemical Co., St. Louis, Mo. MICs with high versus low inocula were previously shown to correlate with hydrolysis of these agents by a partially purified enzyme preparation (12) . The effects of clavulanic acid and sulbactam were determined as previously described (12) .
Resistance transfers. Samples (50 pJ) of stationary-phase cultures of HH22 and PA in BHI broth were added to separate tubes containing 4.5 ml of BHI broth and 0.5 ml of stationary-phase JH2-7 cells. For filter matings, the bacterial mixture was collected on filters (0.45-,im pore size), placed on BHI agar, and incubated overnight at 37°C; the resulting growth was suspended in 2.0 ml of 0.9% saline, and 0.2 ml was then plated onto BHI agar containing 1,000 jig of gentamicin per ml or 25 jig of fusidic acid per ml and onto agar containing both. For broth matings, the bacterial mixture from above was incubated without shaking at 37°C for 4 h and then plated on selective agar.
Restriction endonuclease digestion analysis and hybridization. Plasmid DNA from transconjugants was obtained as previously described (11 CFU/ml versus MIC of >1,000 ,ug/ml with 107 CFU/ml). There was little or no difference with methicillin, cephalothin, and imipenen, and the difference with ticarcillin (MIC of 64 ,ug/ml versus 500 ,ug/ml) was intermediate. There was no inoculum effect with vancomycin. Clavulanic acid eliminated the effect of the high inoculum of PA on the MIC of penicillin at a concentration of 2 ,ug/ml (1 jig/ml was previously shown to inhibit the effect of HH22 in this assay [12] ). Sulbactam produced an effect beginning at 4 ,ug/ml and reached its maximum at 25 jig/ml (4 to 50 ,ug/ml was the range previously found with HH22 [12] ).
As with HH22, the beta-lactamase of PA was not released spontaneously into the medium as judged by lack of betalactamase activity in supernatants even after concentration 100-fold. Whole cells were as active as sonicated fractions. There was no evidence of beta-lactamase induction, since multiple passages (daily for 14 days) in media without antibiotics generated colonies that produced hydrolysis of nitrocefin that was as rapid as that of colonies grown in the presence of subinhibitory concentrations of ampicillin or methicillin. There was also no evidence of zone truncation when disks of methicillin, cefoxitin, or imipenem were placed in proximity to disks of penicillin.
Resistance transfers. Both HH22 and PA transferred Gmr to JH2-7 on filters and in broth. Frequencies of transfer (expressed as transconjugants per donor) were approximately 100-fold higher when HH22 was the donor. One hundred transconjugants generated by each donor were screened for the transfer of other resistances, and the percentages of resistant transconjugants from HH22 and PA, respectively, were as follows: erythromycin, 95 and 90%; streptomycin, 1 and 95%; tetracycline, 1 and 92%; chloramphenical, 98% for PA (HH22 is Cms); and penicillinase production, 100 and 100%.
DNA studies. EcoRI-digested plasmid DNA from the enterococcal transconjugants XH22, XPA-a, and XPA-b is shown in Fig. 1 . There are few, if any, fragments common to both XH22 (Fig. 1A, lane c) and XPA-a (lane a) or XPA-b (lane b); the latter two differ only with respect to the size of their largest EcoRI fragment. From the cloning studies, one ampicillin-resistant Tcr Cms recombinant colony was shown for further study. This strain contained a 9.1-kb plasmid designated pBEM1; EcoRI digestion generated the vector (4.0 kb) and an insert of 5.1 kb. The DNA shown in Fig. 1B was hybridized to the 5.1-kb penicillinase-encoding EcoRI insert from pBEM1, and the resulting autoradiograph is shown in Fig. 1C ; the 5.1-kb fragment hybridized to itself in XH22 plasmid DNA digests (Fig. iB, lane c; Fig. 1C, lane c') and to a 10.2-kb fragment of both XPA-a and XPA-b. This cloned fragment also hybridized to pJM13, a recombinant plasmid containing staphylococcal penicillinase genes (9) (data not shown). The 840-base-pair HindIII-XbaI staphylococcal Bla+ probe hybridized to the 5.1-and 10.2-kb fragments of XH22 and XPAa, respectively. Autoradiograms for the same strains using DNA digested with EcoRI plus HindIll also showed strong homology between the 5.1-kb fragment and different-sized fragments of XH22, XPA-a, and XPA-b.
DISCUSSION
Enterococci are important causes of endocarditis and urinary tract infections and are often present in wound infections related to bowel contamination. Therapy of enterococcal infection is hindered by the fact that these organisms are intrinsically resistant to many commonly used agents such as clindamycin, aminoglycosides, the penicillinase-resistant semisynthetic penicillins, and the cephalosporins, including the newer compounds (17, 18) . Acquired plasmid-mediated resistance to erythromycin, chloramphenicol, and tetracycline is common, as is high-level resistance to streptomycin, kanamycin, and, more recently, gentamicin; high-level aminoglycoside resistance eliminates the synergistic bactericidal activity of adding these agents to penicillin (2, 5, 6, 14, 16) . The newest resistance trait acquired by enterococci is the production of beta-lactamase. This origin of this enzyme appears to be staphylococci, since plasmid DNA from both strains hybridized to an 840-base-pair DNA fragment consisting of the leader sequence and 80% of the structural gene of a staphylococcal penicillinase gene (9) . The spread from staphylococci is not surprising, since other resistance genes and plasmids are known to be common to both genera and in some instances can be shown to transfer between staphylococci and streptococci (2, 15) . Why betalactamase has not spread sooner into enterococci or into other members of the family Streptococcaceae is not known.
The early papers on staphylococcal Bla+ isolates described small plasmids that were spread by phage transduction; since enterococci are not known to be transducible and since the staphylococcal phage may not be able to infect streptococci, this may have limited the spread (2). Staphylococcal
Bla+ is now known to occur on larger, conjugative Gmr plasmids, which provides an explanation for the recent appearance of both of these resistance traits in enterococci (8) .
Although we have failed to find additional beta-lactamaseproducing enterococci in Houston, another such strain (PA) was isolated in Pennsylvania. This strain resembles HH22 in that it was identified as S. faecalis with resistance to high levels of all aminoglycosides and to erythromycin and tetracycline; unlike HH22, PA was also Cmr. The enzyme from PA (like that from HH22) was cell bound, was constitutively produced, showed activity typical of a penicillinase, and was inhibited by clavulanic acid more than by sulbactam. Transfer of Gmr from PA to JH2-7 occurred and was always accompanied by the transfer of penicillinase production. Certain features, including the different frequencies of transfer and the high association of the transfer of Gmr pcr from PA but not HH22 with Smr, Cmr, and Tcr suggested that the Gmr pcr plasmids of PA and HH22 were not the same. EcoRI-digested plasmid DNA also showed the differences between the Gmr pcr plasmids of HH22 and PA (Fig. 1) . The 5.1-kb penicillinase encoding the fragment cloned from XH22 was found to hybridize to a single 10.2-kb fragment of XPA-a and XPA-b; this indicates that there are some homologous sequences, perhaps the Bla+ determinants, but that they are differently arranged.
It is unfortunate that the enterococcal penicillinases are most active against those penicillins that are normally the most effective against enterococci. The agents which remain active against these strains include imipenem and vancomycin as well as clavulanic acid plus a penicillin. None, however, is bactericidal alone, so that therapy of severe infections such as endocarditis still requires the administration of an aminoglycoside. Since both pcr strains are highly resistant to all available aminoglycosides, there is no aminoglycoside which shows synergy (10, 14) . The inability to identify antibiotic regimens synergistic against the Gmr pcr stains indicates that such organisms will likely present major difficulties when they cause infections such as endocarditis which require bactericidal therapy for an optimal cure rate.
In summary, the appearance of penicillinase in enterococci demonstrates that the apparent barrier of Streptococcaceae to this resistance mechanism has been overcome.
Although such strains are still rare, in both instances penicillinase was found to be plasmid mediated. The fact that the penicillinase activity is transferable and that the genes are on different, or differently arranged, plasmids emphasizes the potential for this property to spread.
